| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |